Search

everythinglearnresearchcommunity

for

Search:↓

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

CTP-543 is generally safe for treating alopecia areata.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

HAPLN1 can promote hair growth and may help treat hair loss.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Both oral and topical minoxidil effectively regrow hair in men with similar results.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The combination of finasteride and minoxidil is as safe and effective as minoxidil alone for improving hair growth in men.

The combination therapy improved hair growth and thickness in people with androgenetic alopecia.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Low-dose dutasteride effectively and safely promotes hair growth in men.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.